- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.92 | 1.92 |
NAV | ₹40.39 | ₹37.42 |
Fund Started | 12 Nov 2018 | 25 Jun 2018 |
Fund Size | ₹3138.46 Cr | ₹5024.00 Cr |
Exit Load | Exit load of 0.50% if redeemed within 1 month. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.92
1.92
NAV
₹40.39
₹37.42
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹3138.46 Cr
₹5024.00 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 46.41% | 47.43% |
3 Year | 21.24% | 23.16% |
5 Year | 30.71% | 30.01% |
1 Year
46.41%
47.43%
3 Year
21.24%
23.16%
5 Year
30.71%
30.01%
Holding Analysis
Equity | 96.59% | 97.87% |
Cash | 3.41% | 2.13% |
Equity
96.59%
97.87%
Cash
3.41%
2.13%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.05% |
Suven Pharmaceuticals Ltd. | 10.82% |
Ipca Laboratories Ltd. | 8.12% |
Cipla Ltd. | 6.85% |
Illumina Inc. (USA) | 5.38% |
Globus Medical Inc | 5.30% |
Alembic Pharmaceuticals Ltd. | 5.12% |
Gland Pharma Ltd. | 4.33% |
Apollo Hospitals Enterprise Ltd. | 4.17% |
Lupin Ltd. | 3.84% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 14.35% |
Dr. Reddy's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 8.07% |
Lupin Ltd. | 4.59% |
Aurobindo Pharma Ltd. | 4.57% |
Gland Pharma Ltd. | 4.22% |
Apollo Hospitals Enterprise Ltd. | 3.80% |
Zydus Lifesciences Ltd. | 2.93% |
Divi's Laboratories Ltd. | 2.69% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Jay Kothari | Dharmesh Kakkad |
Start Date | 16 Mar 2018 | 23 Feb 2021 |
Name
Jay Kothari
Dharmesh Kakkad
Start Date
16 Mar 2018
23 Feb 2021
About Fund
Description | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 12 Nov 2018 | 25 Jun 2018 |
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018
